Innovations in Precision Medicine for Liver Health: Hot Topics From 2023

Friday, November 10, 2023

1:00 pm – 2:00 pm  ET



Precision medicine that incorporates advanced imaging and genetics, as well as tools like artificial intelligence, has the potential to fuel a future of earlier disease detection, diagnosis, and selection of more targeted treatments. Are you aware of the innovations and application of precision medicine tools related to liver disease supported by the latest data? In this 60-minute live symposium, expert faculty will bring you up to date on key topics which include: approaches in precision medicine to assess the liver in health and disease and the latest data in 2023 supporting these approaches. Furthermore, faculty will provide their expert perspectives on the ways precision medicine can be applied in detecting, diagnosing, and treating patients with liver disease. During the Q&A session, you will have an opportunity to ask your questions, so join us in-person at our location in Boston or virtually on our live stream! 




This activity is intended for gastroenterologists/hepatologists, radiologists, cardiologists, primary care physicians, diabetologists/endocrinologists, nurses, nurse practitioners, physician assistants, and other clinicians who treat patients with liver disease.


The goal of this activity is for learners to be better able to understand advances in precision medicine for liver disease and the latest 2023 data.


Upon completion of this activity, participants will: Have increased knowledge regarding the [LIST] [ITEM]Clinical utility of precision medicine approaches in liver health and disease [ITEM]Latest clinical data on precision medicine approaches that integrate imaging technology into liver disease assessment, diagnosis, and treatment [ITEM]Way that artificial intelligence can support clinical decision-making in liver disease[/LIST] Have greater competence related to [LIST] [ITEM]Integrating noninvasive magnetic resonance imaging technology in the management of liver disease[/LIST] Demonstrate greater confidence in their ability to [LIST] [ITEM]Implement noninvasive tests in the assessment of patients with metabolic dysfunction-associated fatty liver disease/metabolic dysfunction-associated steatohepatitis (MAFLD/MASH) in a team-based environment incorporating perspectives of hepatology and radiology[/LIST]


[JALOGO] [MEDSCAPE] In support of improving patient care, Medscape, LLC is jointly accredited with commendation by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

[bold]For Physicians[/bold] Medscape, LLC designates this live activity for a maximum of 1.0 [italic][bold]AMA PRA Category 1 Credit(s)™[/bold][/italic]. Physicians should claim only the credit commensurate with the extent of their participation in the activity. [bold]For Nurses[/bold] Awarded ​1.0​ contact hour(s) of nursing continuing professional development for RNs and APNs.

Hynes Convention Center

900 Boylston Street Room: 311
Boston, MA, 02115
United States